• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4 T 细胞最低点独立预测长期抑制性抗逆转录病毒治疗后 HIV 储存库的大小。

CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.

机构信息

Division of Hematology, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

出版信息

J Clin Virol. 2012 Jan;53(1):29-32. doi: 10.1016/j.jcv.2011.09.018. Epub 2011 Oct 22.

DOI:10.1016/j.jcv.2011.09.018
PMID:22019250
Abstract

BACKGROUND

The level of HIV-1 integrated DNA in CD4 T cells was reported to predict the evolution of untreated HIV-1 infection independently of CD4 cell counts or plasma HIV-1 RNA levels. However, the relevance of reservoir level while on efficient antiretroviral therapy (ART) is still unknown.

OBJECTIVES

To evaluate factors that may contribute to the establishment and maintenance of HIV-1 reservoir size in ART-treated HIV-1-infected adults with complete suppression of viremia.

STUDY DESIGN

35 subjects receiving ART with plasma HIV-1 RNA below the limit of detection for an average duration of 3.2 years were studied. A highly sensitive PCR was used to assess HIV-1 integrated DNA levels in sorted CD4 T cells.

RESULTS

The mean HIV-1 integrated DNA was 300±7copies/10(6) CD4 cells (range 10-1408). In univariate analysis, the levels of HIV-1 proviral DNA appeared to be independent of duration of HIV-1-infection, duration on ART, time since HIV-1 viral load was undetectable, delay between HIV-1 infection and starting ART, or viral load before starting ART. Conversely, CD4 T cell nadir, CD4/CD8 ratio and, to lesser degree, CD4 T cell counts were inversely associated with HIV-1 proviral DNA levels. In multivariate analysis, only CD4 T cell nadir significantly predicted levels of HIV-1 proviral DNA (P=0.025).

CONCLUSIONS

CD4 T cell nadir strongly predicted reservoir size independently of other factors in HIV-1-infected adults with complete suppression of viremia. Collectively, these results indicate that the extent of CD4 T cell depletion before ART drives the size of the viral reservoir after prolonged therapy.

摘要

背景

HIV-1 整合 DNA 水平可预测未经治疗的 HIV-1 感染的进展,与 CD4 细胞计数或血浆 HIV-1 RNA 水平无关。然而,在高效抗逆转录病毒治疗(ART)时,储库水平的相关性尚不清楚。

目的

评估在病毒血症完全抑制的接受 ART 治疗的 HIV-1 感染成人中,可能有助于建立和维持 HIV-1 储库大小的因素。

研究设计

研究了 35 名接受 ART 治疗、血浆 HIV-1 RNA 低于检测下限平均 3.2 年的患者。使用高度敏感的 PCR 检测分选 CD4 T 细胞中的 HIV-1 整合 DNA 水平。

结果

平均 HIV-1 整合 DNA 为 300±7copies/10(6) CD4 细胞(范围 10-1408)。在单变量分析中,HIV-1 前病毒 DNA 水平似乎与 HIV-1 感染持续时间、ART 持续时间、HIV-1 病毒载量不可检测的时间、HIV-1 感染和开始 ART 的时间延迟或开始 ART 前的病毒载量无关。相反,CD4 T 细胞最低点、CD4/CD8 比值以及程度较小的 CD4 T 细胞计数与 HIV-1 前病毒 DNA 水平呈负相关。在多变量分析中,只有 CD4 T 细胞最低点显著预测 HIV-1 前病毒 DNA 水平(P=0.025)。

结论

在病毒血症完全抑制的 HIV-1 感染成人中,CD4 T 细胞最低点可独立于其他因素强烈预测储库大小。综上所述,这些结果表明,ART 前 CD4 T 细胞耗竭的程度驱动了长时间治疗后病毒储库的大小。

相似文献

1
CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.CD4 T 细胞最低点独立预测长期抑制性抗逆转录病毒治疗后 HIV 储存库的大小。
J Clin Virol. 2012 Jan;53(1):29-32. doi: 10.1016/j.jcv.2011.09.018. Epub 2011 Oct 22.
2
Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.在接受高效抗逆转录病毒治疗(HAART)且病毒血症低于1000拷贝/毫升的患者循环CD4(+) T细胞中检测和定量原病毒HIV-1 184 M/V 。
J Clin Virol. 2005 Dec;34(4):257-67. doi: 10.1016/j.jcv.2005.02.015. Epub 2005 Apr 18.
3
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.在接受高效抗逆转录病毒治疗且血浆病毒载量长期检测不到的HIV-1感染患者中,CD4+细胞低水平再生所涉及的机制。
J Infect Dis. 2005 May 15;191(10):1670-9. doi: 10.1086/429670. Epub 2005 Apr 5.
4
Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.长期治疗男性患者中强化拉替拉韦对血液和肠道黏膜 HIV 前病毒 DNA 的影响:一项随机对照试验。
AIDS. 2012 Jan 14;26(2):167-74. doi: 10.1097/QAD.0b013e32834e8955.
5
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。
Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.
6
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.抑制性抗逆转录病毒治疗期间CD4 + T细胞恢复的决定因素:免疫激活、T细胞成熟标志物与细胞内HIV-1 DNA的关联
J Infect Dis. 2006 Jul 1;194(1):29-37. doi: 10.1086/504718. Epub 2006 May 18.
7
Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.尽管病毒发生了进化且耐药基因型的选择非常有限,但高效抗逆转录病毒疗法仍能长期抑制血浆病毒血症。
J Med Virol. 2004 Jul;73(3):350-61. doi: 10.1002/jmv.20098.
8
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy.接受联合抗逆转录病毒治疗的患者中CD4(+) T细胞计数的估计年均变化率。
Antivir Ther. 2010;15(4):563-70. doi: 10.3851/IMP1559.
9
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.原发性感染时开始的短期抗逆转录病毒治疗后HIV-1的控制:患者特征的作用及治疗效果
Antivir Ther. 2012;17(6):1001-9. doi: 10.3851/IMP2273. Epub 2012 Aug 6.
10
Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.常规临床样本中全细胞相关及整合型人类免疫缺陷病毒1型(HIV-1)DNA形式的坐标测量方法的开发:其水平与临床参数无关,但低水平的整合型HIV-1 DNA可能对持续成功治疗具有预后意义。
J Clin Microbiol. 2007 Apr;45(4):1288-97. doi: 10.1128/JCM.01926-06. Epub 2007 Feb 21.

引用本文的文献

1
Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection.急性和慢性治疗的HIV-1 C亚型感染中HIV-1储存库大小、景观特征和衰减动态的差异。
Elife. 2025 Feb 20;13:RP96617. doi: 10.7554/eLife.96617.
2
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.评估三十年来临床抗逆转录病毒疗法在HIV-1储存库方面取得的进展。
J Clin Invest. 2024 Nov 29;135(2):e183952. doi: 10.1172/JCI183952.
3
People Living With HIV Have More Intact HIV DNA in Circulating CD4+ T Cells if They Have History of Pulmonary Tuberculosis.
有肺结核病史的HIV感染者,其循环CD4+ T细胞中的完整HIV DNA更多。
Pathog Immun. 2024 Sep 23;9(2):172-193. doi: 10.20411/pai.v9i2.722. eCollection 2024.
4
Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection.急性和慢性治疗的HIV-1 C亚型感染中HIV-1储存库大小、景观特征和衰减动力学的差异。
medRxiv. 2024 Oct 9:2024.02.16.24302713. doi: 10.1101/2024.02.16.24302713.
5
A Two-Faced Gut Microbiome: Butyrogenic and Proinflammatory Bacteria Predominate in the Intestinal Milieu of People Living with HIV from Western Mexico.两面派的肠道微生物组:来自墨西哥西部的 HIV 感染者的肠道环境中以产丁酸菌和促炎菌为主。
Int J Mol Sci. 2024 Apr 29;25(9):4830. doi: 10.3390/ijms25094830.
6
Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies.HIV-1与SIV储存库之间的定量和定性差异:对HIV-1治愈相关研究的启示。
Viruses. 2024 Mar 27;16(4):514. doi: 10.3390/v16040514.
7
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.在接受治疗后仍持续存在的细胞发生HIV-1感染的时间,并不受前病毒的复制能力或细胞嗜性的强烈影响。
PLoS Pathog. 2024 Feb 29;20(2):e1011974. doi: 10.1371/journal.ppat.1011974. eCollection 2024 Feb.
8
A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?一项加拿大的 HIV-1 潜伏研究调查——我们现在在哪里,我们将走向何方?
Viruses. 2024 Feb 1;16(2):229. doi: 10.3390/v16020229.
9
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.HIV 感染者中不确定潜能的克隆性造血的风险因素:来自 REPRIEVE 试验的报告。
Blood Adv. 2024 Feb 27;8(4):959-967. doi: 10.1182/bloodadvances.2023011324.
10
Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy.与接受抗逆转录病毒治疗的 HIV 感染者的 HIV DNA 储存库大小相关的免疫和病毒学参数。
J Infect Dis. 2024 Jun 14;229(6):1770-1780. doi: 10.1093/infdis/jiad595.